Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Oncol., 18 September 2025

Sec. Gastrointestinal Cancers: Gastric and Esophageal Cancers

Volume 15 - 2025 | https://doi.org/10.3389/fonc.2025.1669677

Correction: IGF2BP2 regulates gastric cancer radiotherapy resistance through HIF1α-mediated glycolysis

This article is a correction to:

  1. IGF2BP2 regulates gastric cancer radiotherapy resistance through HIF1α-mediated glycolysis

    1. Read original article
Qi Zhang,&#x;Qi Zhang1,2†Xiaoyu Liu&#x;Xiaoyu Liu5†Yukan Chen&#x;Yukan Chen1†Ruilin Wang&#x;Ruilin Wang1†Shuangyan ZhaoShuangyan Zhao1Yuting TianYuting Tian1Shuping Li,,*Shuping Li1,3,4*Xiaojun Liu,,*Xiaojun Liu1,3,4*
  • 1The First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou, Gansu, China
  • 2Xi'an International Medical Center Hospital, Xian, Shanxi, China
  • 3Department of Radiation Oncology II, Gansu Provincial Hospital, Lanzhou, Gansu, China
  • 4The Third Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China
  • 5The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China

A Correction on
IGF2BP2 regulates gastric cancer radiotherapy resistance through HIF1α-mediated glycolysis

By Zhang Q, Liu X, Chen Y, Wang R, Zhao S, Tian Y, Li S and Liu X (2025). Front. Oncol. 15:1512177. doi: 10.3389/fonc.2025.1512177

In the published article, there was an error regarding the affiliation(s) for “Shuping Li” and “Xiaojun Liu”. As well as having affiliations “The Third Clinical Medical College of Lanzhou University, Lanzhou, Gansu, China”, they should also have “The First Clinical Medical College of Gansu University of Chinese Medicine, Lanzhou, Gansu, China;Department of Radiation Oncology II, Gansu Provincial Hospital, Lanzhou, Gansu, China”.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: IGF2BP2, HIF1α, glycolysis, radioresistance, gastric cancer

Citation: Zhang Q, Liu X, Chen Y, Wang R, Zhao S, Tian Y, Li S and Liu X (2025) Correction: IGF2BP2 regulates gastric cancer radiotherapy resistance through HIF1α-mediated glycolysis. Front. Oncol. 15:1669677. doi: 10.3389/fonc.2025.1669677

Received: 20 July 2025; Accepted: 02 September 2025;
Published: 18 September 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Zhang, Liu, Chen, Wang, Zhao, Tian, Li and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Shuping Li, MTMzMjEyMDMzMzBAMTg5LmNu; Xiaojun Liu, bHhqbWFpbDIwMDhAMTI2LmNvbQ==

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.